nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLC22A2—Cytarabine—lymphatic system cancer	0.121	0.154	CbGbCtD
Quinidine—SLC22A1—Cytarabine—lymphatic system cancer	0.105	0.134	CbGbCtD
Quinidine—ABCB11—Vincristine—lymphatic system cancer	0.089	0.113	CbGbCtD
Quinidine—CYP1A2—Carmustine—lymphatic system cancer	0.054	0.0686	CbGbCtD
Quinidine—ABCC2—Vincristine—lymphatic system cancer	0.0468	0.0595	CbGbCtD
Quinidine—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0439	0.0557	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—lymphatic system cancer	0.0342	0.0435	CbGbCtD
Quinidine—CYP2C9—Teniposide—lymphatic system cancer	0.0327	0.0415	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—lymphatic system cancer	0.0323	0.041	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0313	0.0397	CbGbCtD
Quinidine—CYP3A7—Vincristine—lymphatic system cancer	0.0313	0.0397	CbGbCtD
Quinidine—SLC22A8—Methotrexate—lymphatic system cancer	0.0298	0.0378	CbGbCtD
Quinidine—ABCC2—Methotrexate—lymphatic system cancer	0.0283	0.036	CbGbCtD
Quinidine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0222	0.0282	CbGbCtD
Quinidine—CYP3A4—Cytarabine—lymphatic system cancer	0.0193	0.0245	CbGbCtD
Quinidine—CYP3A4—Teniposide—lymphatic system cancer	0.019	0.0241	CbGbCtD
Quinidine—ABCB1—Vincristine—lymphatic system cancer	0.0153	0.0194	CbGbCtD
Quinidine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0133	0.0169	CbGbCtD
Quinidine—ABCB1—Methotrexate—lymphatic system cancer	0.00924	0.0117	CbGbCtD
Quinidine—CYP3A4—Vincristine—lymphatic system cancer	0.00914	0.0116	CbGbCtD
Quinidine—Confusional state—Fludarabine—lymphatic system cancer	0.000575	0.0027	CcSEcCtD
Quinidine—Neutropenia—Vincristine—lymphatic system cancer	0.000573	0.00269	CcSEcCtD
Quinidine—Oedema—Fludarabine—lymphatic system cancer	0.00057	0.00268	CcSEcCtD
Quinidine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000567	0.00266	CcSEcCtD
Quinidine—Decreased appetite—Teniposide—lymphatic system cancer	0.000564	0.00265	CcSEcCtD
Quinidine—Renal failure—Carmustine—lymphatic system cancer	0.000563	0.00264	CcSEcCtD
Quinidine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00056	0.00263	CcSEcCtD
Quinidine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000559	0.00262	CcSEcCtD
Quinidine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000559	0.00262	CcSEcCtD
Quinidine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000558	0.00262	CcSEcCtD
Quinidine—Neutropenia—Mitoxantrone—lymphatic system cancer	0.000558	0.00262	CcSEcCtD
Quinidine—Rash—Mechlorethamine—lymphatic system cancer	0.000555	0.0026	CcSEcCtD
Quinidine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000554	0.0026	CcSEcCtD
Quinidine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000551	0.00259	CcSEcCtD
Quinidine—Flushing—Bleomycin—lymphatic system cancer	0.000546	0.00256	CcSEcCtD
Quinidine—Anorexia—Fludarabine—lymphatic system cancer	0.000544	0.00255	CcSEcCtD
Quinidine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000535	0.00251	CcSEcCtD
Quinidine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000531	0.00249	CcSEcCtD
Quinidine—Chills—Bleomycin—lymphatic system cancer	0.000528	0.00248	CcSEcCtD
Quinidine—Bone disorder—Methotrexate—lymphatic system cancer	0.000525	0.00246	CcSEcCtD
Quinidine—Sweating—Vincristine—lymphatic system cancer	0.000524	0.00246	CcSEcCtD
Quinidine—Renal failure—Mitoxantrone—lymphatic system cancer	0.000523	0.00245	CcSEcCtD
Quinidine—Nausea—Mechlorethamine—lymphatic system cancer	0.000523	0.00245	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00052	0.00244	CcSEcCtD
Quinidine—Jaundice—Mitoxantrone—lymphatic system cancer	0.000519	0.00243	CcSEcCtD
Quinidine—Haemoglobin—Carmustine—lymphatic system cancer	0.000516	0.00242	CcSEcCtD
Quinidine—Urticaria—Teniposide—lymphatic system cancer	0.000516	0.00242	CcSEcCtD
Quinidine—Oliguria—Methotrexate—lymphatic system cancer	0.000514	0.00241	CcSEcCtD
Quinidine—Haemorrhage—Carmustine—lymphatic system cancer	0.000514	0.00241	CcSEcCtD
Quinidine—Abdominal pain—Teniposide—lymphatic system cancer	0.000513	0.00241	CcSEcCtD
Quinidine—Body temperature increased—Teniposide—lymphatic system cancer	0.000513	0.00241	CcSEcCtD
Quinidine—Erythema—Bleomycin—lymphatic system cancer	0.000512	0.0024	CcSEcCtD
Quinidine—Sweating—Mitoxantrone—lymphatic system cancer	0.00051	0.00239	CcSEcCtD
Quinidine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000508	0.00239	CcSEcCtD
Quinidine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000497	0.00233	CcSEcCtD
Quinidine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000496	0.00233	CcSEcCtD
Quinidine—Visual impairment—Carmustine—lymphatic system cancer	0.000495	0.00232	CcSEcCtD
Quinidine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000492	0.00231	CcSEcCtD
Quinidine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000486	0.00228	CcSEcCtD
Quinidine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000484	0.00227	CcSEcCtD
Quinidine—Urethral disorder—Vincristine—lymphatic system cancer	0.000481	0.00226	CcSEcCtD
Quinidine—Eye disorder—Carmustine—lymphatic system cancer	0.00048	0.00225	CcSEcCtD
Quinidine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00048	0.00225	CcSEcCtD
Quinidine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000478	0.00224	CcSEcCtD
Quinidine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000478	0.00224	CcSEcCtD
Quinidine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000478	0.00224	CcSEcCtD
Quinidine—Flushing—Carmustine—lymphatic system cancer	0.000477	0.00224	CcSEcCtD
Quinidine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00047	0.0022	CcSEcCtD
Quinidine—Asthenia—Teniposide—lymphatic system cancer	0.000466	0.00218	CcSEcCtD
Quinidine—Pruritus—Teniposide—lymphatic system cancer	0.000459	0.00215	CcSEcCtD
Quinidine—Leukopenia—Bleomycin—lymphatic system cancer	0.000459	0.00215	CcSEcCtD
Quinidine—Cardiac disorder—Vincristine—lymphatic system cancer	0.000455	0.00214	CcSEcCtD
Quinidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000451	0.00211	CcSEcCtD
Quinidine—Mental disorder—Carmustine—lymphatic system cancer	0.00045	0.00211	CcSEcCtD
Quinidine—Malnutrition—Carmustine—lymphatic system cancer	0.000447	0.0021	CcSEcCtD
Quinidine—Erythema—Carmustine—lymphatic system cancer	0.000447	0.0021	CcSEcCtD
Quinidine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000445	0.00209	CcSEcCtD
Quinidine—Diarrhoea—Teniposide—lymphatic system cancer	0.000444	0.00208	CcSEcCtD
Quinidine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000442	0.00207	CcSEcCtD
Quinidine—Chest pain—Bleomycin—lymphatic system cancer	0.000436	0.00205	CcSEcCtD
Quinidine—Myalgia—Bleomycin—lymphatic system cancer	0.000436	0.00205	CcSEcCtD
Quinidine—Coma—Methotrexate—lymphatic system cancer	0.000433	0.00203	CcSEcCtD
Quinidine—Mental disorder—Vincristine—lymphatic system cancer	0.00043	0.00202	CcSEcCtD
Quinidine—Chills—Mitoxantrone—lymphatic system cancer	0.000429	0.00201	CcSEcCtD
Quinidine—Ecchymosis—Methotrexate—lymphatic system cancer	0.000428	0.00201	CcSEcCtD
Quinidine—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000422	0.00198	CcSEcCtD
Quinidine—Confusional state—Bleomycin—lymphatic system cancer	0.000422	0.00198	CcSEcCtD
Quinidine—Vision blurred—Carmustine—lymphatic system cancer	0.000421	0.00198	CcSEcCtD
Quinidine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00042	0.00197	CcSEcCtD
Quinidine—Tremor—Carmustine—lymphatic system cancer	0.000419	0.00197	CcSEcCtD
Quinidine—Oedema—Bleomycin—lymphatic system cancer	0.000418	0.00196	CcSEcCtD
Quinidine—Erythema—Mitoxantrone—lymphatic system cancer	0.000416	0.00195	CcSEcCtD
Quinidine—Vomiting—Teniposide—lymphatic system cancer	0.000413	0.00194	CcSEcCtD
Quinidine—Agitation—Carmustine—lymphatic system cancer	0.000411	0.00193	CcSEcCtD
Quinidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000409	0.00192	CcSEcCtD
Quinidine—Asthenia—Fludarabine—lymphatic system cancer	0.000409	0.00192	CcSEcCtD
Quinidine—Rash—Teniposide—lymphatic system cancer	0.000409	0.00192	CcSEcCtD
Quinidine—Dermatitis—Teniposide—lymphatic system cancer	0.000409	0.00192	CcSEcCtD
Quinidine—Headache—Teniposide—lymphatic system cancer	0.000407	0.00191	CcSEcCtD
Quinidine—Pruritus—Fludarabine—lymphatic system cancer	0.000403	0.00189	CcSEcCtD
Quinidine—Leukopenia—Carmustine—lymphatic system cancer	0.0004	0.00188	CcSEcCtD
Quinidine—Anorexia—Bleomycin—lymphatic system cancer	0.000399	0.00187	CcSEcCtD
Quinidine—Agitation—Vincristine—lymphatic system cancer	0.000392	0.00184	CcSEcCtD
Quinidine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000392	0.00184	CcSEcCtD
Quinidine—Photosensitivity—Methotrexate—lymphatic system cancer	0.000392	0.00184	CcSEcCtD
Quinidine—Hypotension—Bleomycin—lymphatic system cancer	0.000391	0.00183	CcSEcCtD
Quinidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00039	0.00183	CcSEcCtD
Quinidine—Convulsion—Carmustine—lymphatic system cancer	0.000387	0.00182	CcSEcCtD
Quinidine—Nausea—Teniposide—lymphatic system cancer	0.000385	0.00181	CcSEcCtD
Quinidine—Vertigo—Vincristine—lymphatic system cancer	0.000384	0.0018	CcSEcCtD
Quinidine—Leukopenia—Vincristine—lymphatic system cancer	0.000382	0.00179	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000381	0.00179	CcSEcCtD
Quinidine—Chest pain—Carmustine—lymphatic system cancer	0.000381	0.00179	CcSEcCtD
Quinidine—Myalgia—Carmustine—lymphatic system cancer	0.000381	0.00179	CcSEcCtD
Quinidine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000373	0.00175	CcSEcCtD
Quinidine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000373	0.00175	CcSEcCtD
Quinidine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000372	0.00175	CcSEcCtD
Quinidine—Convulsion—Vincristine—lymphatic system cancer	0.00037	0.00174	CcSEcCtD
Quinidine—Confusional state—Carmustine—lymphatic system cancer	0.000368	0.00173	CcSEcCtD
Quinidine—Oedema—Carmustine—lymphatic system cancer	0.000365	0.00171	CcSEcCtD
Quinidine—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000365	0.00171	CcSEcCtD
Quinidine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000363	0.00171	CcSEcCtD
Quinidine—Myalgia—Vincristine—lymphatic system cancer	0.000363	0.00171	CcSEcCtD
Quinidine—Visual disturbance—Methotrexate—lymphatic system cancer	0.000363	0.0017	CcSEcCtD
Quinidine—Vomiting—Fludarabine—lymphatic system cancer	0.000363	0.0017	CcSEcCtD
Quinidine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00036	0.00169	CcSEcCtD
Quinidine—Rash—Fludarabine—lymphatic system cancer	0.00036	0.00169	CcSEcCtD
Quinidine—Dermatitis—Fludarabine—lymphatic system cancer	0.000359	0.00169	CcSEcCtD
Quinidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000357	0.00168	CcSEcCtD
Quinidine—Headache—Fludarabine—lymphatic system cancer	0.000357	0.00168	CcSEcCtD
Quinidine—Tachycardia—Carmustine—lymphatic system cancer	0.000356	0.00167	CcSEcCtD
Quinidine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000354	0.00166	CcSEcCtD
Quinidine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000354	0.00166	CcSEcCtD
Quinidine—Oedema—Vincristine—lymphatic system cancer	0.000348	0.00163	CcSEcCtD
Quinidine—Anorexia—Carmustine—lymphatic system cancer	0.000348	0.00163	CcSEcCtD
Quinidine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000345	0.00162	CcSEcCtD
Quinidine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000342	0.00161	CcSEcCtD
Quinidine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000342	0.0016	CcSEcCtD
Quinidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000341	0.0016	CcSEcCtD
Quinidine—Hypotension—Carmustine—lymphatic system cancer	0.000341	0.0016	CcSEcCtD
Quinidine—Oedema—Mitoxantrone—lymphatic system cancer	0.000339	0.00159	CcSEcCtD
Quinidine—Nausea—Fludarabine—lymphatic system cancer	0.000339	0.00159	CcSEcCtD
Quinidine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000337	0.00158	CcSEcCtD
Quinidine—Shock—Mitoxantrone—lymphatic system cancer	0.000334	0.00157	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000333	0.00156	CcSEcCtD
Quinidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000332	0.00156	CcSEcCtD
Quinidine—Urticaria—Bleomycin—lymphatic system cancer	0.000332	0.00156	CcSEcCtD
Quinidine—Anorexia—Vincristine—lymphatic system cancer	0.000332	0.00156	CcSEcCtD
Quinidine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000331	0.00155	CcSEcCtD
Quinidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000331	0.00155	CcSEcCtD
Quinidine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00033	0.00155	CcSEcCtD
Quinidine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000328	0.00154	CcSEcCtD
Quinidine—Hypotension—Vincristine—lymphatic system cancer	0.000326	0.00153	CcSEcCtD
Quinidine—Dyspnoea—Carmustine—lymphatic system cancer	0.000325	0.00153	CcSEcCtD
Quinidine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000323	0.00152	CcSEcCtD
Quinidine—Ataxia—Methotrexate—lymphatic system cancer	0.000323	0.00152	CcSEcCtD
Quinidine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000318	0.00149	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000317	0.00149	CcSEcCtD
Quinidine—Decreased appetite—Carmustine—lymphatic system cancer	0.000317	0.00149	CcSEcCtD
Quinidine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000317	0.00149	CcSEcCtD
Quinidine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000315	0.00148	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—lymphatic system cancer	0.000311	0.00146	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00031	0.00145	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000309	0.00145	CcSEcCtD
Quinidine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000308	0.00145	CcSEcCtD
Quinidine—Decreased appetite—Vincristine—lymphatic system cancer	0.000303	0.00142	CcSEcCtD
Quinidine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000303	0.00142	CcSEcCtD
Quinidine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000301	0.00141	CcSEcCtD
Quinidine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000301	0.00141	CcSEcCtD
Quinidine—Asthenia—Bleomycin—lymphatic system cancer	0.0003	0.00141	CcSEcCtD
Quinidine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000298	0.0014	CcSEcCtD
Quinidine—Asthma—Methotrexate—lymphatic system cancer	0.000297	0.00139	CcSEcCtD
Quinidine—Pruritus—Bleomycin—lymphatic system cancer	0.000296	0.00139	CcSEcCtD
Quinidine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000295	0.00138	CcSEcCtD
Quinidine—Body temperature increased—Carmustine—lymphatic system cancer	0.000289	0.00135	CcSEcCtD
Quinidine—Abdominal pain—Carmustine—lymphatic system cancer	0.000289	0.00135	CcSEcCtD
Quinidine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000285	0.00134	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000282	0.00132	CcSEcCtD
Quinidine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00028	0.00131	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—lymphatic system cancer	0.000278	0.0013	CcSEcCtD
Quinidine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000277	0.0013	CcSEcCtD
Quinidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000275	0.00129	CcSEcCtD
Quinidine—Abdominal pain—Vincristine—lymphatic system cancer	0.000275	0.00129	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000271	0.00127	CcSEcCtD
Quinidine—Urticaria—Mitoxantrone—lymphatic system cancer	0.00027	0.00126	CcSEcCtD
Quinidine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000269	0.00126	CcSEcCtD
Quinidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000268	0.00126	CcSEcCtD
Quinidine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000268	0.00126	CcSEcCtD
Quinidine—Vomiting—Bleomycin—lymphatic system cancer	0.000266	0.00125	CcSEcCtD
Quinidine—Rash—Bleomycin—lymphatic system cancer	0.000264	0.00124	CcSEcCtD
Quinidine—Dermatitis—Bleomycin—lymphatic system cancer	0.000263	0.00124	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000263	0.00123	CcSEcCtD
Quinidine—Asthenia—Carmustine—lymphatic system cancer	0.000262	0.00123	CcSEcCtD
Quinidine—Renal failure—Methotrexate—lymphatic system cancer	0.000261	0.00122	CcSEcCtD
Quinidine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000257	0.0012	CcSEcCtD
Quinidine—Sweating—Methotrexate—lymphatic system cancer	0.000254	0.00119	CcSEcCtD
Quinidine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00025	0.00117	CcSEcCtD
Quinidine—Asthenia—Vincristine—lymphatic system cancer	0.00025	0.00117	CcSEcCtD
Quinidine—Diarrhoea—Carmustine—lymphatic system cancer	0.00025	0.00117	CcSEcCtD
Quinidine—Nausea—Bleomycin—lymphatic system cancer	0.000248	0.00117	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000247	0.00116	CcSEcCtD
Quinidine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000243	0.00114	CcSEcCtD
Quinidine—Dizziness—Carmustine—lymphatic system cancer	0.000241	0.00113	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000239	0.00112	CcSEcCtD
Quinidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000238	0.00112	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000238	0.00112	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—lymphatic system cancer	0.000238	0.00112	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000235	0.0011	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000233	0.00109	CcSEcCtD
Quinidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000232	0.00109	CcSEcCtD
Quinidine—Vomiting—Carmustine—lymphatic system cancer	0.000232	0.00109	CcSEcCtD
Quinidine—Dizziness—Vincristine—lymphatic system cancer	0.00023	0.00108	CcSEcCtD
Quinidine—Rash—Carmustine—lymphatic system cancer	0.00023	0.00108	CcSEcCtD
Quinidine—Dermatitis—Carmustine—lymphatic system cancer	0.00023	0.00108	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—lymphatic system cancer	0.000229	0.00108	CcSEcCtD
Quinidine—Headache—Carmustine—lymphatic system cancer	0.000229	0.00107	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000225	0.00106	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—lymphatic system cancer	0.000222	0.00104	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—lymphatic system cancer	0.000222	0.00104	CcSEcCtD
Quinidine—Vomiting—Vincristine—lymphatic system cancer	0.000222	0.00104	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000221	0.00104	CcSEcCtD
Quinidine—Rash—Vincristine—lymphatic system cancer	0.00022	0.00103	CcSEcCtD
Quinidine—Dermatitis—Vincristine—lymphatic system cancer	0.000219	0.00103	CcSEcCtD
Quinidine—Headache—Vincristine—lymphatic system cancer	0.000218	0.00102	CcSEcCtD
Quinidine—Nausea—Carmustine—lymphatic system cancer	0.000217	0.00102	CcSEcCtD
Quinidine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000216	0.00101	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000215	0.00101	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000214	0.00101	CcSEcCtD
Quinidine—Rash—Mitoxantrone—lymphatic system cancer	0.000214	0.001	CcSEcCtD
Quinidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000214	0.001	CcSEcCtD
Quinidine—Chills—Methotrexate—lymphatic system cancer	0.000214	0.001	CcSEcCtD
Quinidine—Headache—Mitoxantrone—lymphatic system cancer	0.000213	0.000997	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—lymphatic system cancer	0.000208	0.000978	CcSEcCtD
Quinidine—Erythema—Methotrexate—lymphatic system cancer	0.000207	0.000972	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—lymphatic system cancer	0.000207	0.000972	CcSEcCtD
Quinidine—Nausea—Vincristine—lymphatic system cancer	0.000207	0.000971	CcSEcCtD
Quinidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000202	0.000946	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—lymphatic system cancer	0.000195	0.000916	CcSEcCtD
Quinidine—Vertigo—Methotrexate—lymphatic system cancer	0.000186	0.000873	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—lymphatic system cancer	0.000185	0.00087	CcSEcCtD
Quinidine—Convulsion—Methotrexate—lymphatic system cancer	0.000179	0.000842	CcSEcCtD
Quinidine—Chest pain—Methotrexate—lymphatic system cancer	0.000176	0.000827	CcSEcCtD
Quinidine—Myalgia—Methotrexate—lymphatic system cancer	0.000176	0.000827	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000175	0.000822	CcSEcCtD
Quinidine—Confusional state—Methotrexate—lymphatic system cancer	0.00017	0.0008	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000166	0.000778	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000166	0.000777	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—lymphatic system cancer	0.000164	0.00077	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000163	0.000767	CcSEcCtD
Quinidine—Anorexia—Methotrexate—lymphatic system cancer	0.000161	0.000756	CcSEcCtD
Quinidine—Hypotension—Methotrexate—lymphatic system cancer	0.000158	0.000741	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000154	0.000723	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000151	0.000707	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000147	0.000689	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000146	0.000685	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000139	0.000654	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000138	0.000649	CcSEcCtD
Quinidine—Urticaria—Methotrexate—lymphatic system cancer	0.000134	0.00063	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000134	0.000627	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000134	0.000627	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000125	0.000584	CcSEcCtD
Quinidine—Asthenia—Methotrexate—lymphatic system cancer	0.000121	0.000569	CcSEcCtD
Quinidine—Pruritus—Methotrexate—lymphatic system cancer	0.00012	0.000561	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000116	0.000543	CcSEcCtD
Quinidine—Dizziness—Methotrexate—lymphatic system cancer	0.000112	0.000524	CcSEcCtD
Quinidine—Vomiting—Methotrexate—lymphatic system cancer	0.000107	0.000504	CcSEcCtD
Quinidine—Rash—Methotrexate—lymphatic system cancer	0.000107	0.0005	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000107	0.0005	CcSEcCtD
Quinidine—Headache—Methotrexate—lymphatic system cancer	0.000106	0.000497	CcSEcCtD
Quinidine—Nausea—Methotrexate—lymphatic system cancer	0.0001	0.000471	CcSEcCtD
